Correction to: BMC Public Health20, 1670 (2020).
The original publication of this article contained a typo in the results section of the abstract. The incorrect and correct information is shown below. The original article has been updated.
Incorrect
-
Seroprevalence of HCV antibodies ranged from 2·3% to 82·6% while viraemic infections ranged from 5·7% to 8·2%, where reported.
Correct
-
Seroprevalence of HCV antibodies ranged from 2·3% to 82·8% while viraemic infections ranged from 5·7–82%, where reported.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s12889-020-09515-6.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Nakitanda, A.O., Montanari, L., Tavoschi, L. et al. Correction to: Hepatitis C virus infection in EU/EEA and United Kingdom prisons: Opportunities and challenges for action. BMC Public Health 23, 115 (2023). https://doi.org/10.1186/s12889-022-14317-z
Published:
DOI: https://doi.org/10.1186/s12889-022-14317-z